These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24486007)

  • 1. Postpartum contraceptive choices among ethnically diverse women in New Mexico.
    Singh RH; Rogers RG; Leeman L; Borders N; Highfill J; Espey E
    Contraception; 2014 Jun; 89(6):512-5. PubMed ID: 24486007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z; Madden T; Zhao Q; Secura GM; Allsworth JE; Peipert JF
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
    Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
    Deese J; Philip N; Lind M; Ahmed K; Batting J; Beksinska M; Edward VA; Louw CE; Onono M; Palanee-Phillips T; Smit JA; Baeten JM; Donnell D; Mastro TD; Mugo NR; Nanda K; Rees H; Morrison C
    Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
    Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R
    AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years.
    Bahamondes L; Del Castillo S; Tabares G; Arce XE; Perrotti M; Petta C
    Contraception; 2001 Oct; 64(4):223-5. PubMed ID: 11747871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
    Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of postpartum depot medroxyprogesterone administration among low-income mothers.
    Dozier AM; Nelson A; Brownell EA; Howard CR; Lawrence RA
    J Womens Health (Larchmt); 2014 Mar; 23(3):224-30. PubMed ID: 24443831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate.
    Haddad LB; Cwiak C; Jamieson DJ; Feldacker C; Tweya H; Hosseinipour M; Hoffman I; Bryant AG; Stuart GS; Noah I; Mulundila L; Samala B; Mayne P; Phiri S
    Contraception; 2013 Dec; 88(6):737-43. PubMed ID: 24060297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of long-acting reversible contraception.
    Winner B; Peipert JF; Zhao Q; Buckel C; Madden T; Allsworth JE; Secura GM
    N Engl J Med; 2012 May; 366(21):1998-2007. PubMed ID: 22621627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term, reversible contraception use among high-risk women treated in a university-based gynecology clinic: comparison between IUD and depo-provera.
    Cropsey KL; Matthews C; Campbel S; Ivey S; Adawadkar S
    J Womens Health (Larchmt); 2010 Feb; 19(2):349-53. PubMed ID: 20109106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.